Target intelligence / Profile preview

Long intergenic non-protein coding RNA 910 (LINC00910)

Target
LINC00910
Molecular classification
Other (Long non-coding RNA, lncRNA, specifically "long intergenic non-coding RNA")
01

Overview

Long intergenic non-protein coding RNA 910 (LINC00910) is a long non-coding RNA gene on human chromosome 19, although some sources reference it on chromosome 17, most databases support chromosome 19[3][5]. It does not encode a protein, but like other lincRNAs, it acts as a versatile regulator of gene expression at several molecular levels. LINC00910 can participate in both promoter-like and enhancer-like chromatin interactions, bridging distant DNA loci, altering local chromatin environments, and thereby impacting transcriptional regulation[1][2]. It also influences alternative splicing and gene expression in a cell type-specific manner, likely serving as a scaffold for protein-RNA and nucleic acid interactions. LINC00910 has been found to be differentially expressed in multiple cancers (breast, gastric, lung, osteosarcoma), where it may act as a prognostic marker and may drive tumorigenesis or suppress tumors depending on the context[3][5]. Although its precise molecular mechanisms and broader clinical significance remain under investigation, current evidence points to a key regulatory role in gene networks related to cancer and possibly other diseases, such as polycystic ovary syndrome[1][3][5]. No direct drug interactions, mechanisms of action for drugs, or safety concerns have been reported. LINC00910 is not considered a classical therapeutic target such as a receptor, enzyme, or transporter.

Other names
CTD-3014M21.4LINC00910
02

Biological functions

Regulation of gene expression (transcriptional and post-transcriptional modulation)Chromatin interaction and remodelingModulation of alternative splicingEpigenetic regulation (enhancer- and promoter-like activity)Cell proliferationApoptosis
03

Disease associations

Cancer (implicated in breast, gastric, lung cancer, and osteosarcoma; can act as oncogene or tumor suppressor depending on context)Polycystic ovary syndrome (PCOS)
04

Biomarkers

Prognostic biomarker in some cancers (expression levels correlate with disease risk or patient outcome)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 910 (LINC00910).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 910 (LINC00910).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call